Avista Healthcare Partners, L.P.

Avista Healthcare Partners is a New York-based private equity firm specializing in growth capital and leveraged buyout investments within the middle-market healthcare sector. Founded in 2005, the firm's core mission is to invest in and cultivate healthcare companies, fostering enduring partnerships through its deep industry expertise and a proactive, value-added investment approach. Avista Healthcare Partners partners with businesses that demonstrate strong management teams, stable cash flows, and robust growth prospects.

The firm exclusively targets the healthcare sector, focusing on product and technology businesses across various sub-sectors. These include outsourced pharmaceutical and medtech services, consumer healthcare, medical devices, specialty and generic pharmaceuticals, distribution and diagnostics, and healthcare technology. Avista Healthcare Partners manages pooled investment vehicles for institutional clients and has invested over $10 billion in more than 50 growth-oriented healthcare businesses globally.

Led by CEO David Burgstahler, Avista Healthcare Partners has recently been active in the market. In July 2026, the firm acquired Sanotact Group GmbH, a German vitamins, minerals, and supplements platform. Other recent acquisitions include Xstim in June 2026, and Bentec Medical in April 2026. The firm also launched Birchwell Consumer Health as a new over-the-counter platform in May 2026, with Bag Balm as its initial investment. Avista Healthcare Partners rebranded from Avista Capital Partners in August 2024 to underscore its exclusive focus on healthcare and is recognized as an active ESG investor.